Boston Medical Group SlimFitRx Review: What the Prices, Cancellation Rules and Pharmacy Terms Actually Say

The most consequential moment in Boston Medical Group’s SlimFitRx enrollment may not be the consultation. It may be the point when a medication order moves into shipment. Public documentation says patients can cancel through their account, but it also says prescription sales become final after payment is charged and the package is handed to a carrier. Another page moves cancellation to the following month once shipment has been initiated. Those distinctions deserve attention before a patient authorizes payment.

This documentary review examines Boston Medical Group Telemedicine and its SlimFitRx weight-loss offering through their enrollment, billing and service responsibilities. Official pages consulted October 19, 2026, describe access to semaglutide or tirzepatide, including compounded preparations, subject to professional evaluation. They also advertise several incompatible-looking prices and give conflicting refrigeration statements. The issue is not whether the website documents a GLP-1 offering—it does—but whether a prospective patient can identify the exact offer and obligations that will govern an individual order.

At a glance

Who provides care: The commercial site describes Boston Medical Group as a marketplace connecting patients with independent healthcare providers, not as the direct medical-service provider or medication dispenser.
Sources: [7]
Published prices differ: Pages advertise starting prices of $99/month and $149/month, plans starting at $190/month, and separate 12-week SlimFitRx totals of $699 and $999.
Sources: [7] [11] [12]
Payment is not prescription approval: The commercial disclaimer states that payment does not guarantee a prescription or medication dispensing.
Sources: [7]
Cancellation has an order-status boundary: The return policy makes prescription sales final once payment is charged and the package is handed to a carrier; the steps page says cancellation after shipment initiation applies the following month.
Sources: [3] [12]
Compounded-product disclosure: The commercial site acknowledges that its compounded medication is not FDA approved and that FDA has not verified its safety or effectiveness.
Sources: [7]

Start with the offer, not the lowest advertised number

Boston Medical Group’s pricing cannot be reduced responsibly to one monthly figure. Its commercial page advertises a compounded semaglutide GLP-1 card starting at $99/month and an advanced GLP-1 + GIP card starting at $149/month. Both list four weeks of medication, ongoing provider care, syringes, alcohol pads and educational platform access. On that same page, another headline promotes doctor-led plans starting at $190/month. The consulted documentation does not reconcile those offers or establish which patient qualifies for each starting price.

Other SlimFitRx pages describe 12-week programs rather than the same four-week cards. The cost page lists a $699 total, described as $199/month plus a telemedicine platform fee. The steps page lists $999, described as $299/month plus a $100 platform fee. These are the published descriptions, not independently reconciled invoices. Neither the package duration nor the monthly wording establishes mandatory upfront payment, medication quantity or a minimum contractual commitment.

Before enrolling, ask for a written quote identifying the medicine, compounded formulation, injectable presentation, dispensing pharmacy, initial charge, recurring charge and platform fee. The FAQ’s $199–$299 range depends on medication strength, whereas the commercial page promises a consistent rate despite dose adjustments. Our guide to what belongs in a written GLP-1 quote explains why the controlling offer matters more than choosing the smallest number on the website.

Published price descriptions that need reconciliation before payment
Offer or page	Published amount	Condition or unresolved point
Compounded semaglutide GLP-1 card	Starting at $99/month	Lists four weeks of medication; starting-price eligibility is not established.
Advanced GLP-1 + GIP card	Starting at $149/month	Lists four weeks of medication, support and supplies.
Commercial-page headline	Starting at $190/month	Relationship to the $99 and $149 cards is unexplained.
SlimFitRx cost page	$699 for 12 weeks	Described as $199/month plus a telemedicine platform fee.
SlimFitRx steps page	$999 for 12 weeks	Described as $299/month plus a $100 platform fee.

Sources: [7] [11] [12] [9]

Map the platform, clinician and pharmacy before agreeing

Boston Medical Group’s main site describes a men’s-health network focused on erectile dysfunction and premature ejaculation. SlimFitRx, however, is advertised for both men and women. The commercial subdomain describes a marketplace connecting patients with independently licensed healthcare providers through a patient portal. It explicitly says Boston Medical Group does not directly provide medical services or dispense medication, and that independent providers make clinical decisions. Those are the company’s descriptions, not independent verification of credentials or organizational compliance.

Enrollment begins with a medical-history form and an online consultation. The FAQ says patients must be at least 18, and that some states require a video consultation or live chat. A photograph of the patient and photo identification may be requested. Although the site advertises feedback from a doctor in approximately 24 hours, that is a service expectation, not a guaranteed prescription. Its express disclaimer says payment guarantees neither prescribing nor dispensing.

This division of responsibilities matters if an application is declined, an order is delayed or a clinical question arises after payment. Ask which entity collects each fee, who returns any refundable amount and how to reach the treating clinician separately from customer service. A general support address does not answer every question about clinical accountability. Our guide to platform, clinician and pharmacy responsibilities provides a framework for getting those roles in writing.

Sources: [5] [7] [8] [10]

Separate included services from billing promises

The commercial page presents a broad bundle: confidential telehealth consultations, prescribed medication, supplies, free discreet delivery, ongoing messaging and support. The treatment cards additionally identify platform access and educational content. These inclusions are meaningful, but they should be tied to the selected offer rather than assumed to apply identically to every SlimFitRx page. A separately described telemedicine platform fee makes that clarification especially important. Free delivery means the shipping charge is included; it does not make consultation or treatment free.

The commercial FAQ says medication is billed when shipped, based on the selected treatment plan. It also says patients will be contacted before a refill and a credit-card charge. That does not establish whether every component of the initial payment follows the same timing, whether an initial consultation fee is collected earlier or how a declined application affects fees. Nor does a four-week medication listing establish a calendar-month billing interval. The exact charge date and refill interval remain questions for enrollment.

The FAQ states that insurance is not accepted. It nevertheless allows a prescription to be sent to a local pharmacy, while warning that local medication pricing is not guaranteed. The company characterizes its affiliated-pharmacy channel as the cheapest and most convenient option, but that is a commercial claim. Ask whether choosing another pharmacy changes the bundled price, leaves a platform charge in place or requires paying separately for medication. The documented option should not be mistaken for a promise that network pricing follows the prescription.

Sources: [7] [12] [10]

Cancellation depends on shipment status, not just account access

The FAQ’s invitation to reorder or cancel through an account is straightforward at first glance. The qualification appears elsewhere: the steps page says that if shipment has been initiated, the program can be canceled the following month. The return policy states that all prescription sales are final once payment has been charged and the package handed to USPS, FedEx or UPS. It also says account holders can cancel their subscription or change payment and address details before products ship.

Those statements leave a potentially important gap between initiating shipment and handing a package to the carrier. The consulted pages do not define that interval or identify a precise advance-notice deadline. A patient should therefore ask what order status blocks cancellation, how that status is communicated and whether an account cancellation stops an already queued refill. The practical distinction is explained in our guide to cancellation notice and order status. Saving a dated confirmation can help document what was requested.

Cancellation is not the same as a refund. The documentation does not establish which fees are refundable when a clinician declines treatment, or whether any portion of a 12-week package is recoverable after an early stop. The separate policy for unopened nonprescription items—possible returns within 30 days, with return shipping paid by the buyer—does not create a return right for prescription GLP-1 medication. Do not read that retail provision as an exception to the prescription-sales rule.

Sources: [7] [11] [12] [10] [3]

Identify the actual medication and dispensing channel

SlimFitRx describes using prescription semaglutide or tirzepatide, or compounded versions, alongside dietary changes and exercise. Its FAQ describes subcutaneous injection and says its compounded preparation includes pyridoxine, or vitamin B6. These descriptions do not identify the complete formulation and presentation that every patient would receive. Before authorizing an order, request the product description and pharmacy-specific instructions rather than assuming that a broad program name identifies a standardized medication.

The commercial site says its compounded products are prepared by licensed pharmacies under Section 503A on patient-specific prescriptions. That is a provider claim; this review did not independently verify pharmacy licensure or compliance. The FAQ names Manifest Pharmacy in Greer, South Carolina, and RX Compounding Store in Miami, Florida, as possible dispensers depending on therapy and medication. It does not establish which pharmacy would prepare or dispense a particular patient’s GLP-1 order. Dispensing and compounding should not be treated as interchangeable responsibilities.

There is also a material tension in the product descriptions. One FAQ calls compounded medication as safe and effective as brand-name medication, while the commercial page acknowledges that the compounded product is not FDA approved. FDA states that compounded preparations do not undergo its premarket safety, effectiveness and quality review. Nonapproval alone does not prove clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy—not simply because a clinic advertises them.

Sources: [8] [9] [7] [10] [1]

Delivery promises need a product-specific answer

The commercial page’s 24-hour language concerns clinical approval; filling, packing and shipping come afterward. Elsewhere, the FAQ describes approximately 24 hours for medical feedback. Neither statement promises medication arrival within that period. The SlimFitRx steps page describes monthly deliveries with syringes and alcohol swabs, and anticipates about a one-week delay for the first shipment, attributed by the site to a national shortage. The consulted documentation does not establish a guaranteed delivery date or show that this delay notice applies to every current order.

More significantly, the steps page says medication arrives with ice packs and requires refrigeration, not freezing. The return policy says the company currently does not ship refrigerated products and therefore increased transit time will not affect them. These statements cannot safely be combined into one storage assurance. Ask which written handling instructions apply to the actual injectable product and which party handles a temperature-related complaint. FDA explicitly advises not using an injectable GLP-1 that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy.

The FAQ advertises no-contact delivery without a required signature. The terms also warn that medications shipped through partner pharmacies will not arrive in child-resistant packaging. Those details matter when arranging receipt and storage. For packages lost in transit, the return policy promises reshipment after attempting to locate and redirect the shipment with the carrier. That is a specific lost-package process, not a documented blanket refund or replacement guarantee for every damaged, delayed or temperature-compromised delivery.

Sources: [7] [10] [12] [3] [4] [1]

Confirm access and follow-up before relying on broad claims

The homepage advertises telemedicine in all 50 states, but the commercial FAQ limits service to the United States and says restrictions may depend on the therapy and medication. It says those restrictions are disclosed and confirmed during intake. The narrower statement is the useful planning boundary: general nationwide telemedicine availability does not confirm access to a specific SlimFitRx prescription in a particular state. A state-by-state medication availability matrix was not established in the consulted documentation.

SlimFitRx describes its audience broadly: adults with obesity, overweight with certain risk factors, or excess weight they find particularly bothersome. That description does not set a numerical BMI threshold or establish individual eligibility. The provider’s adverse-effects page lists known hypersensitivity to the drug or its components and a personal or family history of MEN 2 (multiple endocrine neoplasia syndrome type 2) or medullary thyroid cancer as contraindications. It also identifies histories of pancreatitis or retinopathy as relative contraindications, with a thorough eye examination and specialist follow-up advised for retinopathy. These are the provider’s stated screening restrictions, not an individualized eligibility assessment. The pages also do not settle laboratory requirements. NIDDK emphasizes that medication selection involves medical history, other medicines, benefits, side effects and cost. A marketing description of the intended audience is therefore not a substitute for the treating clinician’s assessment or a promise that enrollment will lead to prescribing.

Ongoing provider care and messaging are advertised, but the consulted pages do not establish a follow-up schedule, support hours or a guaranteed message-response time. Those are service-contract questions as well as care-delivery questions. Ask who handles symptoms, who authorizes refills and what happens when a clinical question remains unanswered near the next charge. NIDDK describes follow-up as assessing tolerance and response; continuing payments alone do not document that process. The English-language pages also do not confirm Spanish-language consultations or support.

Sources: [8] [10] [5] [7] [2] [6]

Use the support channels to close the documentary gaps

The return policy directs order and product problems to +1 213-415-2632 or rx@bostonmedicalgroup.com. The account portal is the documented route for reordering, cancellation and certain pre-shipment changes. These are useful contact paths, but the pages do not establish that a billing representative can resolve a prescribing question or a pharmacy handling concern. Ask for the appropriate clinical and pharmacy contacts before the first shipment, rather than depending on a general inbox when an issue becomes urgent.

A practical pre-enrollment request would cover the applicable price page, initial and subsequent charges, billing interval, pharmacy, product description, refill authorization and shipment cutoff. It should also ask what happens financially if treatment is not prescribed or an order cannot be supplied. Our guide to refund boundaries and exclusions explains why a cancellation option and a refund entitlement are separate questions. Here, the public documentation provides a clear final-sale boundary but not a complete answer for every earlier payment scenario.

Written clarification is particularly valuable because these inconsistencies concern more than promotional wording. The dose-related pricing descriptions could change the expected bill; the shipment rules could change whether cancellation takes effect now or next month; and the refrigeration conflict affects how a delivery problem should be handled. A satisfactory answer should identify the terms attached to the actual order. Repeating a general promise of affordable treatment, nationwide access or ongoing support would not resolve those specific uncertainties.

Sources: [3] [10] [7] [9] [12]

Questions & answers

Is SlimFitRx definitely $99 a month?

No single price is established for every patient. The commercial page advertises compounded semaglutide starting at $99/month, but also displays other starting prices. Separate SlimFitRx pages describe $699 and $999 totals for 12 weeks. Ask which offer applies, what formulation it covers, whether a platform fee is separate and what subsequent charges will be. The lowest starting figure should not be treated as a universal quote.

Sources: [7] [11] [12]

Does a 12-week program mean I must pay for all 12 weeks upfront?

The consulted pages do not establish that requirement. They publish 12-week totals and monthly descriptions, while the commercial FAQ says medication is billed when shipped under the selected plan. Package duration alone does not establish prepayment or a minimum commitment. Request the actual payment schedule and cancellation consequences before authorizing the order, including whether any consultation or platform fee is collected separately.

Sources: [11] [12] [10]

Can I cancel after a refill has started shipping?

Do not assume cancellation will stop that order. The steps page says cancellation after shipment initiation applies the following month. The return policy makes prescription sales final after payment is charged and the package is handed to the carrier. Account cancellation is available before shipment, but the precise operational cutoff is not defined. Ask support to confirm the order’s status and the effective cancellation date in writing.

Sources: [12] [3]

Can Boston Medical Group send my prescription to my own pharmacy?

The FAQ says its doctors can send a prescription to a local pharmacy chosen by the patient. It does not guarantee that pharmacy’s medication price. The company promotes its affiliated network as the cheaper, more convenient channel, but the consulted pages do not establish how outside dispensing changes the bundled program charge. Confirm product availability and both parties’ charges before choosing that route.

Sources: [10]

What if my injectable medication arrives warm?

FDA advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. Boston Medical Group’s pages conflict: the steps page describes ice packs and refrigeration, while the return policy says refrigerated products are not shipped. Its documented order-support contacts are +1 213-415-2632 and rx@bostonmedicalgroup.com. The public policy does not establish a temperature-specific refund guarantee.

Sources: [1] [12] [3]

Does paying for enrollment guarantee medication?

No. The commercial disclaimer expressly says payment does not guarantee a prescription or dispensing; independent providers make clinical decisions. The documentation also does not establish exactly which payments would be refunded after a declined prescription. Before paying, ask whether the initial amount includes a nonrefundable consultation or platform charge, when medication charges occur and how a clinical denial affects any remaining balance.

Sources: [7] [10]

Our assessment

Boston Medical Group documents a substantive telemedicine weight-loss offering: online intake, independent prescribing, medication and supply bundles, pharmacy options, messaging and account-based cancellation. Its public terms also disclose an important limitation clearly: payment does not guarantee treatment, and a shipped prescription order can become a final sale. Those disclosures give prospective patients useful starting points. The weakness is that the documentation does not connect them into one consistent, patient-specific agreement. Multiple prices, conflicting dose-pricing descriptions, uncertain prepayment obligations and contradictory refrigeration statements remain material. Before authorizing payment, obtain a written offer that reconciles the medication, pharmacy, initial and recurring charges, cancellation cutoff and delivery handling. If those details cannot be clarified, the published starting prices are not enough to establish what the patient is buying. Contract clarity would improve decision-making; it would not independently verify clinical outcomes, pharmacy compliance or the suitability of treatment.

Visit Boston Medical Group Telemedicine / Boston Medical Group — SlimFitRx™’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Boston Medical Group SlimFitRx Review: What the Prices, Cancellation Rules and Pharmacy Terms Actually Say

At a glance

01Start with the offer, not the lowest advertised number

02Map the platform, clinician and pharmacy before agreeing

03Separate included services from billing promises

04Cancellation depends on shipment status, not just account access

05Identify the actual medication and dispensing channel

06Delivery promises need a product-specific answer

07Confirm access and follow-up before relying on broad claims

08Use the support channels to close the documentary gaps